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The Differential Imaging Features of 
Fat-Containing Tumors in the Peritoneal
Cavity and Retroperitoneum: the
Radiologic-Pathologic Correlation
There are a variety of fat-containing lesions that can arise in the intraperitoneal
cavity and retroperitoneal space. Some of these fat-containing lesions, such as
liposarcoma and retroperitoneal teratoma, have to be resected, although resec-
tion can be deferred for others, such as adrenal adenoma, myelolipoma,
angiomyolipoma, ovarian teratoma, and lipoma, until the lesions become large or
symptomatic. The third group tumors (i.e., mesenteric panniculitis and
pseudolipoma of Glisson’s capsule) require medical treatment or no treatment at
all. Identifying factors such as whether the fat is macroscopic or microscopic with-
in the lesion, the origin of the lesions, and the presence of combined calcification
is important for narrowing the differential diagnosis. The development and wide-
spread use of modern imaging modalities make identification of these factors
easier so narrowing the differential diagnosis is possible. At the same time,
lesions that do not require immediate treatment are being incidentally found at an
increasing rate with these same imaging techniques. Thus, the questions about
the treatment methods have become increasingly important. Classifying lesions
in terms of the necessity of performing surgical treatment can provide important
information to clinicians, and this is the one of a radiologist’s key responsibilities.
here are a variety of fat-containing lesions that can arise in the intraperi-
toneal cavity and retroperitoneal space (Table 1). Many authors use the
organ of origin, the location of the fat-containing lesions or their
malignancy to classify these lesions. With the development and wide-spread use of
modern imaging modalities, incidental lesions that do not require immediate treatment
are being detected increasingly. Therefore, the radiologist’s role in differentiating
lesions that require surgical therapy from those that do not is becoming more
important. To do this, meticulous evaluation of fat-containing lesions for various
characteristic features is essential to help avoid unnecessary surgical treatments.
Fat Seen on Imaging
On ultrasound (US) images, fat tissues usually appear hyperechoic, although there
are exceptions. On computed tomography (CT), fat appears to have low attenuation
with a range of -10 to -100 Hounsfield units (HUs). If the proportion of fat within a
voxel is small, then the mean CT number will increase and fat may be difficult to
reliably identify (1). Magnetic resonance (MR) imaging is more sensitive for detecting
microscopic fat than CT or US. Fat appears hyperintense on the T1-weighted images
and it appears intermediately intense to hyperintense on the T2-weighted fast spin-
echo and gradient-echo images. MR imaging techniques use the difference of the
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Tresonance frequencies of water and fat protons, such as in-
phase/opposed-phase chemical shift imaging and the
frequency-selective fat suppression techniques, and this
can help identify fat more reliably (2).
Neoplasm Indicated for Removal
Liposarcoma
Liposarcomas are the most common primary retroperi-
toneal malignant neoplasm. They may also arise in the
mesentery or peritoneum. Liposarcomas are histologically
subdivided into five main subgroups in the order of
increasing malignancy: 1) well-differentiated, 2) myxoid, 3)
dedifferentiated 4) round cell and 5) pleomorphic liposar-
coma (5) (Table 2). The CT and MR imaging appearances
vary depending on the histologic subtype and the tumor
components. For liposarcomas, surgical resection that is
usually combined with the adjacent kidney is necessary,
but complete surgical removal may be difficult and
recurrence is common (3). The histologic subtype and the
margin of the resection are prognostic factors for survival
for patients with primary retroperitoneal liposarcoma (4).
Radiologists play an important role not only in making the
preoperative diagnosis, but also in correctly assessing the
extent of the tumor.
Well-differentiated liposarcomas resemble lipomas,
although liposarcomas tend to be larger and have dense
collagen bands. Atypical hyperchromatic cells with angular
nuclei and lipoblasts can also be seen (5). Well-differenti-
ated liposarcomas may be sub-classified into three
subtypes: 1) adipocytic (or lipoma-like) (Fig. 1), 2) scleros-
ing, and 3) inflammatory. The lipoma-like subtype shows
low attenuation on CT images and high signal intensity on
the T1- and T2-weighted MR images, similar to subcuta-
neous fat. The fibrous septa may be thicker, more irregular
or more nodular than those seen in lipomas (2). The
sclerosing subtype shows CT attenuation or an MR signal
intensity that approximates the characteristics of muscle.
The septa within the lipoma-like components and scleros-
ing components can be homogeneously enhanced on
contrast-enhanced CT and on the fat-suppressed T1-
weighted MR images after administration of gadolinium
chelate (6). The inflammatory subtype, which is relatively
rare and has the histological feature of an extensive
lymphoplasmacytic infiltration, appears as a fibro-fatty
mass on CT. The inflammatory component may show a
homogeneous hyperintense signal on the T2-weighted MR
images (7).
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Table 1. Fat-Containing Lesions in Intraperitoneal Cavity and Retroperitoneal Space
Intraperitoneal Cavity Retroperitoneal Space Characteristic Features
Indicated for removal Liposarcoma Liposarcoma Lobulated or ill-marginated fatty mass with soft 
tissue component
Retroperitoneal teratoma Encapsulated round or ovoid fatty mass with dense 
calcification. It is found in retroperitoneum
Immature teratoma Coarse calcification, dominant soft tissue 
component and smaller fat foci
Renal cell carcinoma Predominant hypervascular renal mass that may be 
associated with macroscopic fat and calcification
Indicated for removal  Adrenal adenoma Microscopic fat in mass and mass originates 
only when symptomatic  from adrenal gland
or large Myelolipoma Macroscopic fat in mass and mass originates 
from adrenal gland
Angiomyolipoma Macroscopic fat in mass. Mass originates 
from kidney
Mature cystic teratoma of  Fat-fluid level +/- calcification in well-
ovary encapsulated mass. Mass originates from 
ovary
Lipoma Lipoma Homogeneous, fat attenuated mass +/- thin 
fibrous septa
Miscellaneous Mesenteric panniculitis Fatty mass surrounding superior mesenteric 
vessels without vessel narrowing
Pseudolipoma of Glisson’s  Small nodule on liver surface and nodule 
capsule shows fat attenuation or signal intensity on liver
surface The myxoid and round cell liposarcomas represent a
morphologic continuum, and the histologic grading is based
on the extent of the round cell component (4). Myxoid
liposarcoma is the most common subtype of liposarcomas.
Myxoid liposarcoma has a prominent myxoid stroma with
or without delicate arborizing vasculature (4). The myxoid
components show less attenuation than that of muscle on
CT scans, with similar signal intensity to that of water, and
they are hypointense compared with muscle on the T1-
weighted images and hyperintense compared with fat on
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Fig. 1. 64-year-old man with pathologically proven lipoma-like, well-differentiated liposarcoma. 
A. Contrast-enhanced CT scan shows well-defined, heterogeneous mass with predominant fat attenuation (arrow). Slightly coarse and
thickened fibrous septa (open arrow) with enhancement suggest lipoma-like, well-differentiated liposarcoma. 
B. Photograph of gross pathologic specimen shows homogeneously yellow adipose tissue (arrow) and septal structure (open arrow). 
C. Photomicrograph (Hematoxylin & Eosin staining, ×200) demonstrates mature adipocytes (arrow) that exhibit variations of cell size
and multi-vacuolated lipoblasts (arrowhead) with fibrous septa (open arrow). 
ABC
Table 2. Subtypes of Liposarcoma
Liposarcoma Subtypes Clinicopathological Feature Imaging Findings
Well-differentiated Adipocytic  Resemble lipomas Lipoma-like component
(or lipoma-like) Larger size - Similar to subcutaneous fat
Dense collagen bands - Fibrous septa: thicker, more irregular or more
nodular than those seen in lipomas
Sclerosing Collagenous fibrous tissue Sclerosing component
- Similar to muscle
- Homogeneous contrast enhancement
Inflammatory An extensive lymphoplasmacytic  Well-defined non-lipomatous masses 
infiltrate juxtaposed with fatty tumor
Inflammatory component
- Homogeneous signal intensity on T2 weighted image
Myxoid Uniform round-to-oval-shaped  Myxoid component
primitive nonlipogenic  - Mimics a cystic lesion on precontrast CT or MRI
mesenchymal cells  - Gradual reticular enhancement
Prominent myxoid stroma 
+/- delicate arborizing vasculature
Round cell  More round cell components Nonspecific soft-tissue masses
Less myxoid matrix and capillary networks
Pleomorphic  Pleomorphic spindle cells and giant cells Nonspecific soft-tissue masses
Sheets of pleomorphic lipoblasts
Dedifferentiated Well-differentiated liposarcoma  Well-defined non-lipomatous masses 
juxtaposed to pleomorphic sarcoma juxtaposed with fatty tumor
Non-lipomatous mass
- Homogeneous signal intensity on T2 weighted imagethe T2-weighted spin-echo images. The fibrous septa
within the myxoid components show low signal intensity
on the T2-weighted MR images (6) (Fig. 2). Before contrast
enhancement, the myxoid components show CT attenua-
tion and MR signal intensity similar to that of fluid. Lacy,
linear or amorphous regions of high signal intensity can be
noted on the T1-weighted images and intermediate signal
intensity can noted on the T2-weighted images, which
represent intratumoral fat, and these features permit
making the correct diagnosis. Recognition of chemical shift
artifacts between the water- and fat-based components also
facilitates an accurate diagnosis. After contrast enhance-
ment, gradual reticular enhancement may be seen within
the myxoid components. Although myxoid liposarcomas
may appear to be cystic lesions before contrast enhance-
ment, they can be correctly characterized as solid lesions
on the contrast-enhanced images (2).
Round cell liposarcoma contains more round cell
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ABC
Fig. 2. 64-year-old man with pathologi-
cally proven retroperitoneal myxoid
liposarcoma. 
A. Unenhanced transverse CT scan
shows slightly inhomogeneous, hypoat-
tenuated lesion compared with muscle,
with mean CT number of 18 HU; range
of attenuation was -34 HU to 66 HU.
Note septae (arrow) within tumor. 
B. Transverse contrast-enhanced CT
scan shows enhancing septae (arrow)
and non-fatty tumor components (open
arrow). 
C. Transverse T2-weighted MR image
shows tumor to be hyperintense in
relation to subcutaneous fat. Low signal
intense septae (arrow) are also noted. 
D, E. Transverse gadolinium-enhanced,
fat-saturated T1-weighted MR images
show slowly progressive enhancement,
which represents solid nature of tumor.
Fibrous septae and non-fatty tumor
components are markedly enhanced. 
F. Photograph of gross pathologic
specimen shows encapsulated soft solid
mass with myxoid cut surface and
whitish fibrous areas. There is no
definite necrotic area. 
G. Photomicrograph (Hematoxylin &
Eosin staining, ×200) demonstrates
arborizing capillaries (arrow) in myxoid
background and adipocytic differentia-
tion (open arrow) at periphery of lesion.
DE
FGcomponents and less myxoid matrix and capillary
networks than myxoid liposarcomas, and round cell
liposarcoma is considered to be a high-grade sarcoma with
a higher likelihood of metastasis and death (8). Round-cell
liposarcoma shows CT attenuation approximating that of
muscle. On the contrast-enhanced CT images, round cell
liposarcoma has heterogeneous enhancement with irregu-
lar hypoattenuation (Fig. 3). On the MR images, round-cell
liposarcoma is seen as a soft tissue mass that is hypointense
relative to muscle on the T1-weighted images, it is slightly
hyperintense relative to muscle on the T2-weighted images
and it shows strong enhancement on the contrast-enhanced
images. These non-fatty tumors can be accompanied with
necrosis or hemorrhage (9). These characteristics are
usually indistinguishable from those of other malignant
soft-tissue masses.
Pleomorphic liposarcoma is the least common subtype; it
is a high-grade, very aggressive tumor. On microscopy,
pleomorphic liposarcoma is characterized by pleomorphic
spindle cells and giant cells, as well as sheets of pleomor-
phic lipoblasts (4). Pleomorphic liposarcoma shows CT
attenuation approximating that of muscle (6). Pleomorphic
liposarcoma exhibits ill-defined and soft-tissue signal
intensity equal to that of muscle on the T1-weighted spin-
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Fig. 3. 45-year-old man with pathologically proven myxoid/round cell liposarcoma. 
A. Axial contrast-enhanced CT scan shows heterogeneous non-fatty mass displacing right kidney superiorly and medially (arrow) with
areas of hypoattenuation that represent myxoid components. 
B. Photomicrograph (Hematoxylin & Eosin staining, ×200) demonstrates undifferentiated round cell morphology with myxoid
component.
AB
Fig. 4. 30-year-old woman with pathologically proven pleomorphic liposarcoma. 
A. Axial contrast-enhanced CT scan shows soft tissue tumor with heterogeneous enhancement. 
B. Axial T2-weighted MR image shows heterogeneous, high signal intense tumor. Signal intensity is similar to or slightly lower than that
of subcutaneous fat.
ABecho MR images and this is equal to that of fat on the T2-
weighted spin-echo MR images without characteristic
manifestations (9) (Fig. 4). There are no characteristic
signals on MRI, so it is very difficult to differentiate this
tumor from other retroperitoneal soft tissue tumors.
Dedifferentiated liposarcoma is most commonly located
in the retroperitoneum, and this is defined as a neoplasm
with a well-differentiated liposarcoma juxtaposed to
pleomorphic sarcoma. On the CT and MR images, dediffer-
entiated liposarcoma is seen as well-defined non-lipoma-
tous masses juxtaposed with fatty tumor (10). On the T1-
weighted MR images, the signals are hypointense relative
to the muscle signals, whereas on the T2-weighted MR
images, the tumors show heterogeneous hyperintense
signals relative to the muscle intensities (Fig. 5). The
heterogeneity on T2-weighted images may be a clue for
differentiation between the inflammatory subtype of well-
differentiated liposarcoma and dedifferentiated liposar-
coma (7). The tumor extent should be defined with caution
as the fat components of the tumor could easily be
mistaken for adjacent normal fat structures, and missed
tumor components could be left after surgical resection
(Fig. 6). According to Tateishi et al. (10), the presence of
calcification or ossification and the first recurrence after a
mean of 13 months, as identified by CT and MRI studies,
are significant adverse prognostic factors for primary
dedifferentiated liposarcoma of the retroperitoneum.
Retroperitoneal Teratoma
Primary retroperitoneal teratomas account for 1-11% of
all retroperitoneal neoplasms (11). These tumors are very
rare in adults, but there is a 26% chance of malignant
change (12). Retroperitoneal teratomas are often located
near the upper pole of the kidney with preponderance on
the left side. They have been confused with ovarian and
adrenal tumors such as adrenal myelolipomas, as well as
with a variety of renal and retroperitoneal masses includ-
ing Wilms’ tumors, renal cysts, retroperitoneal fibromas,
sarcomas, hemangiomas and enlarged lymph nodes (12).
The most characteristic radiologic findings of mature
teratoma of the retroperitoneum are a complex mass that
contains a well-circumscribed fluid component of variable
volume, adipose tissue and/or sebum in the form of a fat-
fluid level, and calcification in either a congealed or linear
strand pattern (13) (Fig. 6). Although the presence of a fat-
fluid level is highly specific for a teratoma, a fat-fluid level
has also been described in a case of well-differentiated
liposarcoma of the retroperitoneum (14). Thus, surgical
resection remains the mainstay of therapy and this is
required for making the definitive diagnosis (11).
Indicated for Removal Only When Symptomatic or
Large
Adrenal Adenoma
Adrenal adenoma is common tumor that is usually
detected incidentally, and it has shown a prevalence of 3%
Shin et al.
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Fig. 5. 56-year-old woman with pathologically proven dedifferentiated liposarcoma.
A. Coronal contrast-enhanced CT image shows non-lipomatous mass (open arrow) abruptly juxtaposed with fatty tumor (arrowhead).
Mass was diagnosed as retroperitoneal soft tissue sarcoma without considering fat component as part of tumor and incomplete resection
was done, which failed to remove neoplastic fat component. Considerable amount of well-differentiated liposarcoma was left. Metaplastic
ossification (arrow), which is adverse prognostic factor, is also noted. 
B. Photomicrograph (Hematoxylin & Eosin staining, ×40) demonstrates abrupt transition from well-differentiated liposarcoma (w) to
hypercellular high-grade sarcoma (p). Pleomorphic cells (arrow) are demonstrated in dedifferentiated area.
ABin a previous autopsy series (15). Although they are
usually nonfunctional, hyperfunctional adenomas can also
occur and they can account for endocrine disorders such as
Cushing syndrome and Conn syndrome. On CT scans,
adrenal adenomas appear as small, well-defined homoge-
neous masses that are typically hypo-attenuating relative
to the liver. A cutoff of 10 HU on the unenhanced CT scan
and a relative percentage of washout of more than 50% on
the delayed study can be used for detecting adenomas (2,
16). Microscopic fat within adrenal adenomas appears as
signal loss on the opposed-phase MR images when
compared with that of the in-phase MR images (Fig. 7).
These chemical shift MR images are more sensitive for
detecting adrenal adenomas than CT scans. If there is
evidence of autonomous adrenal steroid production, then
surgery (either open or laparoscopic) is indicated,
whenever possible, to remove the tumor and to correct
any excess steroid hormone. Therapy can be deferred
when the tumor is an incidental finding, it is small (< 3 or 4
cm) and it has the above-mentioned typical radiographic
features of adrenal adenoma (2, 16).
Angiomyolipoma
Angiomyolipoma (AML) is the most common benign
tumor of the kidney and it is composed of varying amounts
of thick-walled dysplastic or dysmorphic blood vessels,
smooth muscle and mature adipose elements derived from
perivascular epithelioid cells (17). AML is seen in two
distinct clinical settings: 1) sporadic or in association with
tuberous sclerosis. The sporadic form accounts for approxi-
mately 80-90% of the cases of AML and it is most
commonly found in middle-aged women (18). Although
hemorrhage is a frequent complication, necrosis and
calcification are rare. AML can usually be diagnosed in a
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Fig. 6. 33-year-old woman with
periadrenal mature teratoma. 
A. Transverse contrast-enhanced CT
scan shows well encapsulated cystic
mass with fat (arrow) and calcification
(open arrow). Isodense, feathery
appearance (arrowhead) representing
hair is noted. 
B. Macroscopic fat component (arrow)
in cystic mass shows high signal
intensity on T1-weighted gradient-echo
MR image. 
C. Sagittal T1-weighted gradient MR
image shows displaced spleen (arrow)
and left kidney (open arrow). 
D. Photograph of gross pathologic
specimen shows yellowish butter-like
keratinous material with hair follicles
(arrow) and calcified material (open
arrow).
AB
CDstraightforward manner on the US, CT or MR images by
identifying the intratumoral fat component. On sonogra-
phy, AMLs appear hyperechogenic with acoustic shadow-
ing. On CT, these lesions typically appear as well-defined,
cortical masses of predominantly fat attenuation with
heterogeneous soft-tissue attenuation interspersed through-
out. Intratumoral fat is the component that has been best
characterized on the MR images. This fat appears as high
signal intensity on the T1-weighted MR imaging with loss
of signal intensity on the fat-suppressed images (Fig. 8).
The chemical shift misregistration artifact on spin-echo
images and the India ink artifact due to chemical shift
interference between the fat and water interface are also
used for diagnosing AML (19).
Because there have been rare reports of renal cell
carcinomas (RCC) with fat attenuation (less than -20 HU)
on CT and because several renal lesions other than AML
may contain fat, such as liposarcoma, lipoma, myolipoma
and Wilms tumor in children, fat is not diagnostic proof of
AML. AML is also a challenge to diagnose because AML
with minimal fat mimics RCC. AMLs can require
emergency treatment (embolization or surgery) if life-
threatening bleeding occurs, but they do not necessarily
require surgery (20). Surgical resection is necessary for
malignant lesions such as RCC or retroperitoneal liposar-
coma. Therefore, making an accurate diagnosis of AML is
important to prevent unnecessary surgery.
The fat components within RCC can be caused by
engulfment of the perirenal or renal sinus fat into the
tumor, intratumoral bone metaplasia with fatty marrow
elements or the presence of cholesterol necrosis that is
misinterpreted as fat (21). As most RCCs with fat densities
show calcification, fat-containing lesions with calcification
favors a diagnosis of RCC rather than AML and this should
be recommended for surgery (21).
Homogeneous tumor enhancement and prolonged
enhancement patterns on biphasic helical CT may be useful
for differentiating AML with minimal fat from RCC (22).
Large exophytic AMLs and well-differentiated retroperi-
toneal liposarcomas can have similar appearances on
imaging studies. A careful evaluation for a sharp defect in
the renal parenchyma and the presence of enlarged vessels
Shin et al.
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Fig. 7. 33-year-old man with adrenal adenoma. 
A. Transverse unenhanced CT image shows well-demarcated,
low-attenuation mass (arrow) in left adrenal gland. Mean CT
number is 29 HU and this CT result is indeterminate. 
B, C. Transverse in- (B) and opposed-phase (C) chemical shift MR
images show signal loss on opposed-phase image relative to that
on in-phase image, finding that prompts diagnosis of adenoma
(arrows). 
Cand associated AMLs should enable accurately differentiat-
ing these lesions from primary retroperitoneal fatty tumors
in almost all cases (3). In contrast, because liposarcoma
arises in the retroperitoneal fat, it does not cause a defect in
the renal parenchyma, and the interface of the lesion with
the kidney is smooth. AMLs usually contain enlarged vessels
Imaging of Fat-Containing Tumors in Peritoneal Cavity and Retroperitoneum
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Fig. 8. 48-year-old man with angiomy-
olipoma. 
A. Contrast-enhanced CT scan shows
well-defined, cortically based mass with
focal areas of fat attenuation (arrow). 
B. Photomicrograph (Hematoxylin &
Eosin staining, ×100) shows adipocytes
(arrow), smooth muscle cells (M) and
thick-walled vessels (open arrows). 
C, D. These (arrows) appear hyperin-
tense on T1-weighted MR image (C)
with signal loss on gadolinium-enhanced
fat saturation T1-weighted image (D).
AB
CD
Fig. 9. 44-year-old man with adrenal myelolipoma. 
A. Transverse contrast-enhanced CT scan shows well-defined fatty mass (arrow) in adrenal area interspersed with enhancing soft tissue
components (open arrows). 
B. Photomicrograph (Hematoxylin & Eosin staining, ×100) shows areas of myeloid and erythroid precursor cells (open arrows) among
adipocytes (arrow) within mass. Adrenal cortical cells (arrowheads) adjacent to lesion are identified. 
ABthat can be seen with contrast-enhanced CT. In comparison,
well-differentiated liposarcomas are relatively avascular.
The presence of other fatty lesions in the ipsilateral or
contralateral kidney, independent of the dominate lesion, is
a strong indicator that the tumor in question is an AML (3).
Myelolipoma
Myelolipoma is an uncommon tumor and it is composed
of a variable mixture of mature fat and hematopoietic
elements that resembles bone marrow (23). Although most
myelolipomas have been found in the adrenal gland, extra-
adrenal (most often in the retroperitoneum) myelolipomas
also reported (24). Myelolipoma may be accompanied by
acute hemorrhage and calcification, which can complicate
making the image-based diagnosis. On US, myelolipoma
often shows heterogeneous echogenicity due to its nonuni-
form architecture. Myelolipoma is typically seen as a
hyperechogenic mass with more hypoechoic regions in the
predominantly myeloid components (25). CT frequently
demonstrates large amounts of fat with areas of
interspersed higher-attenuation tissue. On MR imaging,
due to the nonuniform mixture fat and marrow
components, the fatty component is usually hyperintense
on the T1-weighted images and heterogeneously hyperin-
tense on the T2-weighted images (2). Frequency-selective
fat-suppressed MR imaging allows confirmation of the
diagnosis of myelolipoma by demonstrating signal loss.
Opposed-phase imaging should demonstrate low signal
intensity in the voxels containing both fat and water tissue
(24) (Fig. 9). Surgical excision is not necessary unless the
diagnosis is in question or the lesion is symptomatic.
Patients with large asymptomatic tumors over 10 cm in
size should also be surgically treated because there is a
small, but distinct risk of developing abdominal pain or
life-threatening shock from spontaneous hemorrhage, and
particularly in the case of large myelolipomas because
hemorrhage often occur in these tumors (26).
It is difficult to differentiate giant adrenal or extra-
adrenal myelolipomas from other fat-containing soft-tissue
masses such as lipoma, liposarcoma, myolipoma, teratoma
and an exophytic AML of the kidney. Therefore, percuta-
neous needle biopsy is often needed to confirm the diagno-
Shin et al.
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Fig. 10. 19-year-old woman with mature cystic teratoma. 
A. On axial contrast-enhanced CT scan, well-encapsulated,
multiloculated cystic and solid lesion shows fat-attenuation (arrow)
with calcifications (open arrow). 
B, C. Heterogeneous internal signal intensity nodule on axial T2-
weighted MR image (B) shows signal loss on axial fat-saturated
T2-weighted MR image (C), and this represents fat component
(arrows).
Csis (27).
Ovarian Teratoma
Ovarian teratomas are the most common germ cell
neoplasm. Mature cystic teratomas (also known as dermoid
cysts) are the most common of these tumors, and mature
cystic teratomas are cystic tumors composed of well-differ-
entiated derivations from at least two of the three germ
cell layers (ectoderm, mesoderm and endoderm). Adipose
tissue is seen in 67-75% of the cases, and teeth are present
in 31% (28). Immature teratomas that demonstrate
clinically malignant behavior have immature or embryonic
tissues. In monodermal teratomas, one of these tissue types
predominates, such as struma ovarii (thyroid tissue),
ovarian carcinoid tumor (neuro-ectodermal tissue), and
tumor with neural differentiation.
Although mature cystic teratomas show various appear-
ances on US, most can be characterized by the presence of
echogenic sebaceous material and calcification. When there
is fat attenuation within a cyst on CT, with or without
calcification in the wall, it is diagnostic of mature cystic
teratoma. On MR imaging, the fat-suppressed images can
specifically identify the sebaceous component (Fig. 10).
The typical US appearances are heterogeneous, partially
solid lesions, usually with scattered calcifications, although
these are non-specific for immature teratomas. Both CT
and MR imaging show the characteristic appearance of
immature teratoma as a large, irregular solid component
containing coarse calcifications. Small foci of fat also help
characterize these tumors, and hemorrhage is often
present. The US features of struma ovarii are also nonspe-
cific, but a complex appearance with multiple cystic and
solid areas may be seen. The cystic spaces demonstrate
both high and low signal intensity on the T1- and T2-
weighted images. On both the T1- and T2-weighted
images, some of the cystic spaces may demonstrate low
signal intensity due to the thick, gelatinous colloid of the
struma. Fat is not evident in these lesions (28).
Mature cystic teratoma can be associated with complica-
tions from torsion, rupture, and malignant degeneration.
Although most mature cystic teratomas are asymptomatic,
the minority of patients with this malady present with
abdominal pain or other nonspecific symptoms. Because of
the slow growth of dermoid cysts (1.8 mm per year),
Imaging of Fat-Containing Tumors in Peritoneal Cavity and Retroperitoneum
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Fig. 11. 70-year-old man with acute pathologically proven
mesenteric panniculitis. Axial contrast-enhanced CT scan shows
ill-defined, inhomogeneous fatty mass with hyperdense peripheral
stripe (arrow). Mesenteric vessels (black arrowhead) with no
distortion and lymph nodes (white arrowhead) are engulfed by
fatty halos (open arrow). Note smooth displacement in adjacent
small bowel loops (white open arrowhead).
Fig. 12. 60-year-old man with pseudolipoma of Glisson’s capsule. 
A. Axial contrast-enhanced CT scan shows well-demarcated, hypoattenuating nodule (arrow) in subcapsular region of right hepatic lobe
with mean CT number of 50 HU. Lesion is not differentiated from metastatic nodule. 
B, C. Nodule appears with high signal intensity on in-phase MR image (B) and nodule (arrows) has signal loss on opposed-phase image
(C). These findings are suggestive of fat-containing pseudolipoma of Glisson’s capsule. 
ABCnonsurgical management for asymptomatic, noncompli-
cated lesions less than 6 cm in diameter is recommended
while immature teratomas require surgical treatment with
or without chemotherapy (29, 30). Mature cystic teratomas
requiring removal can be treated according to age, the
desire to maintain fertility or the presence of another
pelvic pathology rather than their size or bilaterality, and
simple cystectomy is favored for younger patients who
have lower gravidity and parity to preserve as much
ovarian tissue as possible (28, 31).
Miscellaneous
Mesenteric Panniculitis
Mesenteric panniculitis is a rare idiopathic disorder. It
typically involves the adipose tissue of the bowel mesentery
by chronic, nonspecific inflammation. When symptomatic, a
palpable abdominal mass and systemic manifestations can
occur, including abdominal pain, pyrexia, weight loss and
bowel disturbances of variable duration. On the CT images,
mesenteric panniculitis can appear as a solitary ill-defined
mass of inhomogeneous fatty tissue at the root of the
jejunal mesentery (Fig. 11). It is characterized by envelop-
ment of the superior mesenteric vessels without vascular
narrowing, and there is displacement of the adjacent bowel
loops and well-defined soft tissue nodules (lymph nodes)
scattered throughout the mass. A distinctive, hypo-attenuat-
ing fatty halo that typically surrounds the nodules and
vessels is suggestive of mesenteric panniculitis. Yet this is
not specific because it can be found in other entities such as
lymphoma. A hyperattenuating stripe partially surrounding
the mass is also suggestive of the diagnosis of mesenteric
panniculitis (32). There is no specific treatment. Medical
treatment may consist of therapy with anti-inflammatory or
immunosuppressive agents. According to some authors,
steroid treatment may decrease the amount of inflamma-
tion and improve the course of the disease (33). Partial
resection is recommended when the advanced inflamma-
tory changes become irreversible, and especially in the case
of bowel obstruction (34).
Pseudolipomas 
Pseudolipoma is defined as an encapsulated lesion that
contains degenerated fat, and this is all enveloped by a
liver capsule. This tumor is thought to arise from a
detached piece of an epiploic appendage that undergoes
degenerative changes and then it becomes covered by a
fibrous capsule before lodging in the peritoneal cavity (35).
This lesion may become attached to the liver capsule when
it is in close proximity to the liver. The differential
diagnoses of this uncommon entity include serosal metasta-
tic nodule, fibrosing subcapsular necrotic nodule and
parasitic infections such as echinococcosis. On CT, it
appears as a well-circumscribed nodule on the liver surface
with a center of fat or soft-tissue attenuation. On the MR
images, it appears as fat signal intensity on all the MRI
sequences (1) (Fig. 12). Pseudolipoma does not require any
treatment.
CONCLUSION
Identification of fat within an intraperitoneal or
retroperitoneal lesion can help narrow the differential
diagnosis. When such lesions are detected, their origin and
Shin et al.
344 Korean J Radiol 11(3), May/Jun 2010
Fig. 13. Algorithm to differentiate fat-
containing lesions in intraperitoneal
cavity and retroperitoneal space. Bold
letters indicate lesions that require
surgical resection.characteristic imaging features are critical for differentiat-
ing between lesions that need surgical resection and those
that require medical treatment or no treatment at all (Fig.
13). Careful identification of the extent of the tumor is also
important because incomplete resection can have an
adverse effect upon the prognosis.
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